Back
Sage Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
23
SAGE
Sage Therapeutics
Last Price:
7.91
Seasonality Move:
14.13%
Sell
35
BMRN
Biomarin Pharmaceutical
Last Price:
71.43
Seasonality Move:
5.7%
Sell
23
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $7.91. The Score for SAGE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $71.43. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $7.91
The current trend is relatively stagnant and SAGE is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $71.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
SAGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 46.7 | Sell |
Chaikin Money Flow: | 113452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.55 - 8.35) | Sell |
Bollinger Bands (100): | (8.54 - 12.24) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.05 | Sell |
Relative Strength Index (14 RSI): | 23.59 | Sell |
Chaikin Money Flow: | 529461 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (78.7 - 93.16) | Sell |
Bollinger Bands (100): | (78.33 - 88.33) | Sell |
SAGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.58 | Buy |
20-day SMA: | 7.83 | Buy |
50-day SMA: | 9.17 | Sell |
200-day SMA: | 15.76 | Sell |
8-day EMA: | 7.67 | Buy |
20-day EMA: | 7.9 | Buy |
50-day EMA: | 8.93 | Sell |
200-day EMA: | 15.13 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.73 | Sell |
20-day SMA: | 84.51 | Sell |
50-day SMA: | 85.71 | Sell |
200-day SMA: | 86.92 | Sell |
8-day EMA: | 76.32 | Sell |
20-day EMA: | 81.77 | Sell |
50-day EMA: | 84.33 | Sell |
200-day EMA: | 86.01 | Sell |
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $0.23 per share, an increase this year of $2.99 per share, and an increase next year of $1.38 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Sage Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |